Impact of uricosurics on mortality outcomes in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Chia Siang Kow, Dinesh Sangarran Ramachandram, Shahzad Syed, Hasan, Kaeshaelya Thiruchelvam
Objectives: To determine risks associated with uricosurics in COVID-19 patients.
Methods: A systematic review and meta-analysis was conducted by systematically searching electronic databases.
Key findings: The pooled analysis of the included trials revealed that the use of uricosurics was not associated with the risk of mortality (pooled odds ratio [OR] = 1.03, 95% confidence interval [CI]: 0.94-1.12). However, there is a potential mortality benefit associated with the use of ascorbic acid (pooled OR = 0.78, 95% CI: 0.65-0.94).
Conclusions: The findings confirmed the safety of uricosurics in COVID-19 patients, despite their potential to cause uric acid excretion, which may possess antioxidant properties.
Supplementary material Supplementary data are available at International journal of Pharmacy Practice online. validation; roles/writing-original draft; writing-review & editing; final approval of the version to be published. All authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The manuscript has been seen and approved by all authors. We confirm that this work is original and has not been published elsewhere, nor is it currently under consideration for publication elsewhere. All authors had complete access to the study data that support the publication.
Author contributions
Conflict of interest The authors have no conflicts of interest to declare that are relevant to the content of this article.
References
Kow, Hasan, Ramachandram, The effect of vitamin C on the risk of mortality in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials, Inflammopharmacology,
doi:10.1093/ijpp/riae003/7619074bygueston05
Kurajoh, Hiura, Numaguchi, Inflammation related to asssociation of low uric acid and progression to severe disease in patients hospitalized for non-severe Coronavirus disease 2019, Biomedicines,
doi:10.3390/biomedicines11030854
Topless, Gaffo, Stamp, Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study, Lancet Rheumatol,
doi:10.1016/S2665-9913(21)00401-X